http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1524893-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c41cad1060112c68fb09672bc9b7635e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1989-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6d8aeebc7a9afe442869e23abd8873 |
publicationDate | 1989-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SU-1524893-A1 |
titleOfInvention | Method of treatment of glaucoma |
abstract | This invention relates to ophthalmology. The aim of the invention is to reduce postoperative complications. After retro-bulbar anesthesia and akinesia, the conjunctiva is opened in a semicircular 6 mm from the limbus and concentric to it. After hemostasis with a trephine, 2 mm in diameter, the required number of scleral perforations (11 to 22) is calculated in a staggered manner on the basis of an increase in the initial coefficient of ease of outflow after a single trepanation at 0.01 mm 3 / min / mm Hg. Then, using tweezers and razor blades, the intended scleral flaps are excised. A solution of sulfacyl sodium is instilled into the wound. On conjunctiva impose bioshov. Under the conjunctiva, antibiotic and steroid hormone solutions are administered. Aseptic dressing is applied. |
priorityDate | 1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4022878 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451856544 |
Total number of triples: 14.